Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Orsini Federici

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Diabetes Care|February 15, 2008
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?Massimo Massi-Benedetti, Marco Orsini-Federici
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|May 20, 2003
The artificial pancreasPaolo Brunetti, Marco Orsini Federici, Massimo Massi Benedetti
Diabetes/Metabolism Research and Reviews|April 26, 2021
Changing the approach to type 2 diabetes treatment: A comparison of glucagon-like peptide-1 receptor agonists and sulphonylureas across the continuum of careMarco Orsini Federici, Raffaella Gentilella, Antonella Corcos, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 25, 2019
Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with DiabetesAntonio Nicolucci, Antonio Ceriello, Paolo Di Bartolo, et al.
Diabetes Technology & Therapeutics|August 21, 2007
Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetesPier Giorgio Fabietti, Valentina Canonico, Marco Orsini-Federici, et al.
Pediatric Diabetes|June 10, 2019
Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes in the real-life, post-Diabetes Control and Complications Trial setting: A systematic reviewValentino Cherubini, Ivana Rabbone, Fortunato Lombardo, et al.
Medical & Biological Engineering & Computing|August 26, 2006
Control oriented model of insulin and glucose dynamics in type 1 diabeticsPier Giorgio Fabietti, Valentina Canonico, Marco Orsini Federici, et al.
Clinical Chemistry and Laboratory Medicine|May 10, 2006
National survey on the execution of the oral glucose tolerance test (OGTT) in a representative cohort of Italian laboratoriesMarco Orsini Federici, Andrea Mosca, Roberto Testa, et al.
Drug Target Insights|November 17, 2021
Serena Losi, Cesare Celeste Federico Berra, Riccardo Fornengo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 12, 2018
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort StudyMarco Orsini Federici, Janette McQuillan, Giovanni Biricolti, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Diabetes Care|February 15, 2008
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?Massimo Massi-Benedetti, Marco Orsini-Federici
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|May 20, 2003
The artificial pancreasPaolo Brunetti, Marco Orsini Federici, Massimo Massi Benedetti
Diabetes/Metabolism Research and Reviews|April 26, 2021
Changing the approach to type 2 diabetes treatment: A comparison of glucagon-like peptide-1 receptor agonists and sulphonylureas across the continuum of careMarco Orsini Federici, Raffaella Gentilella, Antonella Corcos, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 25, 2019
Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with DiabetesAntonio Nicolucci, Antonio Ceriello, Paolo Di Bartolo, et al.
Diabetes Technology & Therapeutics|August 21, 2007
Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetesPier Giorgio Fabietti, Valentina Canonico, Marco Orsini-Federici, et al.
Pediatric Diabetes|June 10, 2019
Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes in the real-life, post-Diabetes Control and Complications Trial setting: A systematic reviewValentino Cherubini, Ivana Rabbone, Fortunato Lombardo, et al.
Medical & Biological Engineering & Computing|August 26, 2006
Control oriented model of insulin and glucose dynamics in type 1 diabeticsPier Giorgio Fabietti, Valentina Canonico, Marco Orsini Federici, et al.
Clinical Chemistry and Laboratory Medicine|May 10, 2006
National survey on the execution of the oral glucose tolerance test (OGTT) in a representative cohort of Italian laboratoriesMarco Orsini Federici, Andrea Mosca, Roberto Testa, et al.
Drug Target Insights|November 17, 2021
Serena Losi, Cesare Celeste Federico Berra, Riccardo Fornengo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 12, 2018
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort StudyMarco Orsini Federici, Janette McQuillan, Giovanni Biricolti, et al.
Pageof 3